Management of Hemophilic Arthropathy of the Ankle

Author(s): E. Carlos Rodriguez-Merchan*.

Journal Name: Cardiovascular & Hematological Disorders-Drug Targets
(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)

Volume 17 , Issue 2 , 2017

Become EABM
Become Reviewer

Graphical Abstract:


Background: Hemophilic arthropathy (HA) of the ankle is prevalent in people with hemophilia (PWH). It is frequently severe and incapacitating, due to recurrent bleeding into the ankle articulation during infancy. Around 50% of hemophilic patients suffer from ankle pain and radiological signs of HA.

Objective: To review current treatment of HA of the ankle in PWH.

Method: A literature review of hemophilic ankle arthropathy in PWH was performed utilizing MEDLINE (PubMed) and the Cochrane Library.

Results: Primary hematologic prophylaxis could keep away from the development of ankle HA if the level of the patient's deficient factor is prevented from dropping below 1% of normal. Recurrent articular bleeding can be prevented by the intravenous infusion of clotting factor concentrates (prophylaxis). Major articular bleeds and chronic hemophilic synovitis should be managed fiercely to prevent ankle HA. In the circumstance of advancing articular involvement, some noninvasive and invasive procedures can procure symptomatic mitigation and ameliorate the patient’s function and quality of life.

Conclusion: The ideal treatment for the hemophilic ankle when hematologic prophylaxis fails includes physical medicine and rehabilitation, orthoses, radiosynovectomy, arthroscopic ankle debridement (in the initial stages of cartilage degeneration), and ankle distraction, ankle fusion or total ankle replacement (in advanced stages of cartilage degeneration).

Keywords: Hemophilia, ankle, hemophilic arthropathy, treatment, hemorrhages, radiosynovectomy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [111 - 118]
Pages: 8
DOI: 10.2174/1871529X17666170908110758
Price: $58

Article Metrics

PDF: 35